Ethics Talk: Unblinding COVID-19 Vaccine Trials
In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Dr Steven Goodman about the ethical and scientific implications of unblinding COVID-19 vaccine trials.
Click here to read the transcript.
Steven Goodman, MD, MHS, PhD is Associate Dean of Clinical and Translational Research and Professor of Medicine and of Epidemiology and Population Health at Stanford School of Medicine.
Video
Audio
Conflict of Interest Disclosure
Interviewee had no conflicts of interest to disclose.
Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.
Issue
Legacies of the Holocaust in Health Care
CME
Off
Ethics Talk: Equity and Intellectual Property Protection of COVID Vaccines
In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Prof Ana Santos Rutschman about the impact of intellectual property regimes on domestic and global responses to the COVID-19 pandemic.
Click here to read the transcript.
Ana Santos Rutschman, SJD is an assistant professor of law at the Saint Louis University School of Law.
Video
Recorded on April 28, 2021
Audio
Conflict of Interest Disclosure
Interviewee had no conflicts of interest to disclose.
Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.
Issue
Ending the HIV Epidemic
CME
Off
Ethics Talk: Could Trusting Science Mean Not Trusting Some FDA Decisions?
In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Dr Caleb Alexander about the US Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's Disease.
Click here to read the transcript.
G. Caleb Alexander, MD, MS is professor of epidemiology and medicine at Johns Hopkins Bloomberg School of Public Health.
Video
Recorded on June 22, 2021
Neurology Patient Care
Audio
Conflict of Interest Disclosure
Dr Alexander is past chair and current member of FDA's Peripheral and Central Nervous System Drugs Advisory Committee. He is a co-founding principal and equity holder in Monument Analytics, a health care consultancy whose clients include the life sciences industry as well as plaintiffs in opioid litigation. He was also a member of OptumRx's National Pharmacy and Therapeutics Committee.
Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.
Issue
Visibility and Measurability in Health Care
Off
